TipRanks
TG Therapeutics (DE:NKB2)
FRANKFURT:NKB2
Germany Market
NKB2
TG Therapeutics
RESEARCH TOOLSreports

TG Therapeutics (NKB2) Balance Sheet

3 Followers

TG Therapeutics Balance Sheet

TG Therapeutics's total assets for Q2 2026 were $1.64B, an increase of 7.25% from the previous quarter. DE:NKB2 total liabilities were $1.04B for the fiscal quarter, a 9.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.06B$ 577.69M$ 329.59M$ 193.57M$ 379.63M
Total Liabilities
$ 415.23M$ 355.33M$ 169.09M$ 134.99M$ 142.48M
Total Equity Gross Minority
$ 648.02M$ 222.36M$ 160.50M$ 58.59M$ 237.15M
Other Metrics
Currency in USD

TG Therapeutics Debt to Assets